3. Sawaya R, Bindal RK, Lang FF, Abi-Said D: Metastatic brain tumors. In Brain tumors. An encyclopedic approach. 2nd edition. Edited by: Churchill Livingstone. London: Kaye AH and Laws Jr ER; 2001:999–1026. 4. Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger this website AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer
JJ, Rosenfeld SS, Shrieve DC, Sills AK Jr, Spence AM, Vrionis FD: Central nervous system cancers: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netv 2005, 3:644–690. 5. Langer CJ, Mehta MP: Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005, 23:6207–6219.PubMedCrossRef 6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analsis (RPA) of prognostic factors in three Radiation buy BVD-523 therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745–751.PubMedCrossRef 7. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795–803.PubMedCrossRef 8. Meyers CA, Smith JA, Bezjak A,
Mehta MP, Liebmann J, Illidge https://www.selleckchem.com/products/3-deazaneplanocin-a-dznep.html T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar
LE, Curran W, Phan SC, Miller RA, Renschler MF: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 22:157–165.PubMedCrossRef 9. Bradley KA, Ponatinib Mehta MP: Management of brain metastases. Semin Oncol 2004, 31:693–701.PubMedCrossRef 10. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C: EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 2006, 13:674–681.PubMedCrossRef 11. Langer CJ, Mehta MP: Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005, 23:6207–6219.PubMedCrossRef 12. Fabi A, Vidiri A, Ferretti G, Felici A, Papaldo P, Carlini P, Mirri A, Nuzzo C, Cognetti F: Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow? Cancer Invest 2006, 24:466–468.PubMedCrossRef 13. Cappuzzo F, Ardizzoni A, Soto-Parra H, Gridelli C, Maione P, Tiseo M, Calandri C, Bartolini S, Santoro A, Crinò L: Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). Lung Cancer 2003, 41:227–231.PubMedCrossRef 14. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457–481.CrossRef 15.